Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4 Hydroxyproline
2. 4-hydroxyproline
3. Cis 4 Hydroxyproline
4. Cis-4-hydroxyproline
5. Hydroxyproline
6. Oxyproline
1. (2s)-4-hydroxypyrrolidine-2-carboxylic Acid
2. 4-hydroxyproline
3. 6912-67-0
4. Cis-hydroxyproline
5. The (r)-4-hydroxy L-isomer Has Been Assumedunless Otherwise Specified Or Implied In The Original Document And Is Indexed At L-proline,4-hydroxy-,(4r)- [51-35-4]. When Synthetichydroxyproline Has Been Clearly Indicated In Theoriginal Document,the 4-hydroxy
6. Proline, 4-hydroxy-
7. L-allohydroxyproline
8. Allo-l-hydroxyproline
9. Allo-4-hydroxyproline
10. Allo-hydroxy-l-proline
11. L-proline, Allo-hydroxy-
12. L-proline, 4-hydroxy-, Cis-
13. Proline, 4-allo-hydroxy-, L-
14. Nsc 206274
15. 4-hydroxy-proline
16. 4hydroxy-l-proline
17. 30724-02-8
18. Cis-4-hydroxy-l-pro
19. 4-hydroxy-(l)-proline
20. 4-cis-hydroxy-l-proline
21. Schembl21184
22. 4-hydroxy-l-proline, (z)-
23. L-proline, Allo-hydroxy-, Cis
24. Chebi:18240
25. Cis-proline, 4-allo-hydroxy-, L-
26. As-10781
27. Cs-0526696
28. H0296
29. A820581
30. Q27102938
| Molecular Weight | 131.13 g/mol |
|---|---|
| Molecular Formula | C5H9NO3 |
| XLogP3 | -3.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 131.058243149 g/mol |
| Monoisotopic Mass | 131.058243149 g/mol |
| Topological Polar Surface Area | 69.6 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 125 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A 4-Hydroxy-L-Proline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-Hydroxy-L-Proline, including repackagers and relabelers. The FDA regulates 4-Hydroxy-L-Proline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-Hydroxy-L-Proline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 4-Hydroxy-L-Proline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 4-Hydroxy-L-Proline supplier is an individual or a company that provides 4-Hydroxy-L-Proline active pharmaceutical ingredient (API) or 4-Hydroxy-L-Proline finished formulations upon request. The 4-Hydroxy-L-Proline suppliers may include 4-Hydroxy-L-Proline API manufacturers, exporters, distributors and traders.
click here to find a list of 4-Hydroxy-L-Proline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
4-Hydroxy-L-Proline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-Hydroxy-L-Proline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-Hydroxy-L-Proline GMP manufacturer or 4-Hydroxy-L-Proline GMP API supplier for your needs.
A 4-Hydroxy-L-Proline CoA (Certificate of Analysis) is a formal document that attests to 4-Hydroxy-L-Proline's compliance with 4-Hydroxy-L-Proline specifications and serves as a tool for batch-level quality control.
4-Hydroxy-L-Proline CoA mostly includes findings from lab analyses of a specific batch. For each 4-Hydroxy-L-Proline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-Hydroxy-L-Proline may be tested according to a variety of international standards, such as European Pharmacopoeia (4-Hydroxy-L-Proline EP), 4-Hydroxy-L-Proline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-Hydroxy-L-Proline USP).
LOOKING FOR A SUPPLIER?
